Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Novel tachykinin NK1 antagonists prepared and tested by Takeda

April 7, 2006

MediciNova begins phase I study for urinary incontinence treatment MN-246

April 4, 2006

Phase III hepatorenal syndrome study of terlipressin completes enrollment

March 27, 2006

Enrollment completed in second phase III study of Sanctura XR

March 24, 2006

Enrollment completed in phase II study of TH-070 for BPH

March 23, 2006

Novel urological agents disclosed in recent patent literature

March 21, 2006

ALK5 inhibitor a novel therapeutic approach for the treatment of fibrosis

March 20, 2006

TGF-beta1 gene-silencing treatment for progressive renal diseases

March 17, 2006

Intravenous and oral conivaptan raises serum sodium in heart failure patients

March 17, 2006

Enrollment completed in first of two phase III studies for Sanctura XR

March 9, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...